IGX Solutions

Embed and evidence EMA and EU medicines duties

In your words: “EMA and EU medicines requirements are difficult to embed and evidence”

  • GxP compliance
  • EMA medicines regulation
  • Lifecycle traceability
01 · Where you start

GMP, GDP, GCP, GLP and GVP responsibilities span quality, manufacturing, clinical operations, safety, regulatory affairs and external partners. This becomes most visible when an audit, regulatory change, incident or assurance request requires the organisation to prove how an obligation operates in practice.

02 · What makes the difference

Connecting procedures, roles, systems, controls and inspection evidence across the medicinal-product lifecycle keeps them aligned as things change.

03 · What changes when you get it right

Consistency reduces deviation and inspection risk, and change becomes faster and cheaper.

04 · How to get there

A connected GxP process architecture improves traceability, change impact, controlled execution and inspection readiness. In practical terms, change and assurance can be managed as connected operational work, with accountable remediation and evidence available by design.

05 · What you gain
  • Greater GxP consistency, faster inspection preparation and safer, more controlled lifecycle change
  • Faster regulatory impact assessment
  • Earlier detection of control and evidence gaps
  • Reduced audit and inspection preparation
  • Defensible traceability from duty to execution
06 · Questions to ask yourself
  • Which GxP processes cross the greatest number of functions and partners?
  • Can a changed requirement be traced to every affected SOP and workflow?
  • How quickly can inspection evidence be assembled?
  • Which obligation is hardest to trace to a named operational owner and control?
  • What evidence would prove implementation rather than policy publication?
07 · What the research says

EMA states that organisations across medicine development, manufacture, marketing and distribution are responsible for compliance with applicable EU pharmaceutical standards.

EMA: Compliance Overview

EMA describes GMP as the minimum standard for medicines manufacturing processes and coordinates inspections to verify and harmonise compliance across the EU.

EMA: Good manufacturing practice

Talk to IGX to trace one GxP requirement through the affected process, roles, systems, controls and inspection evidence.

Talk to IGX